Skip to main content

Posts

Showing posts from February, 2018
From the FDA: Early Alzheimer’s Disease: Developing Drugs for Treatment Guidance for Industry (Draft Guidance) February 2018 Early Alzheimer’s Disease: Developing Drugs for Treatment Guidance for Industry (Draft Guidance)